Is hydroxychloroquine beneficial for COVID-19 patients?

被引：61
|
作者：
Li, Xing [1 ]
Wang, Ying [2 ]
Agostinis, Patrizia [3 ]
Rabson, Arnold [4 ]
Melino, Gerry [5 ]
Carafoli, Ernesto [6 ]
Shi, Yufang [2 ,7 ]
Sun, Erwei [1 ,8 ]
机构：
[1] Southern Med Univ, Affiliated Hosp 3, Dept Rheumatol & Immunol, 183 Zhongshan Ave West, Guangzhou 510630, Guangdong, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Shanghai Inst Biol Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China
[3] Katholieke Univ Leuven, VIB KU Leuven Ctr Canc Biol, Leuven, Belgium
[4] Rutgers State Univ, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ USA
[5] Univ Roma Tor Vergata, TOR, I-00133 Rome, Italy
[6] Univ Padua, Venetian Inst Mol Med, Rome, Italy
[7] Soochow Univ, State Key Lab Radiat Med & Protect, Affiliated Hosp 1, Inst Translat Med,Med Coll, Suzhou, Peoples R China
[8] Southern Med Univ, Shunde Hosp, Dept Rheumatol & Immunol, Peoples Hosp Shunde 1, Foshan 528000, Guangdong, Peoples R China
来源：
CELL DEATH & DISEASE | 2020年 / 11卷 / 07期
关键词：
ANTIMALARIAL-DRUGS; CHLOROQUINE; INFECTION; INHIBIT; CELLS;
D O I：
10.1038/s41419-020-2721-8
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019. As similar cases rapidly emerged around the world(1-3), the World Health Organization (WHO) declared a public health emergency of international concern on January 30, 2020 and pronounced the rapidly spreading coronavirus outbreak as a pandemic on March 11, 2020(4). The virus has reached almost all countries of the globe. As of June 3, 2020, the accumulated confirmed cases reached 6,479,405 with more than 383,013 deaths worldwide. The urgent and emergency care of COVID-19 patients calls for effective drugs, in addition to the beneficial effects of remdesivir(5), to control the disease and halt the pandemic.
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Is hydroxychloroquine beneficial for COVID-19 patients?
    Xing Li
    Ying Wang
    Patrizia Agostinis
    Arnold Rabson
    Gerry Melino
    Ernesto Carafoli
    Yufang Shi
    Erwei Sun
    Cell Death & Disease, 11
  • [2] Hydroxychloroquine in Hospitalized Patients with Covid-19
    Lacout, Alexis
    Perronne, Christian
    Lounnas, Valere
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09): : 881 - 882
  • [3] Hydroxychloroquine and COVID-19
    Sinha, Neeraj
    Balayla, Galit
    POSTGRADUATE MEDICAL JOURNAL, 2020, 96 (1139) : 550 - 555
  • [4] Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs
    Yu, Bo
    Li, Chenze
    Chen, Peng
    Li, Jia
    Jiang, Hualiang
    Wang, Dao-Wen
    SCIENCE CHINA-LIFE SCIENCES, 2021, 64 (02) : 330 - 333
  • [5] Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs
    Bo Yu
    Chenze Li
    Peng Chen
    Jia Li
    Hualiang Jiang
    Dao-Wen Wang
    Science China(Life Sciences), 2021, (02) : 330 - 333
  • [6] Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs
    Bo Yu
    Chenze Li
    Peng Chen
    Jia Li
    Hualiang Jiang
    Dao-Wen Wang
    Science China Life Sciences, 2021, 64 : 330 - 333
  • [7] Hydroxychloroquine in Hospitalized Patients with Covid-19 Reply
    Horby, Peter
    White, Nicholas J.
    Landray, Martin J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09): : 882 - 882
  • [8] Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
    Horby, Peter
    Mafham, Marion
    Linsell, Louise
    Bell, Jennifer L.
    Staplin, Natalie
    Emberson, Jonathan R.
    Wiselka, Martin
    Ustianowski, Andrew
    Elmahi, Einas
    Prudon, Benjamin
    Whitehouse, Tony
    Felton, Timothy
    Williams, John
    Faccenda, Jakki
    Underwood, Jonathan
    Baillie, J. Kenneth
    Chappell, Lucy C.
    Faust, Saul N.
    Jaki, Thomas
    Jeffery, Katie
    Lim, Wei Shen
    Montgomery, Alan
    Rowan, Kathryn
    Tarning, Joel
    Watson, James A.
    White, Nicholas J.
    Juszczak, Edmund
    Haynes, Richard
    Landray, Martin J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (21): : 2030 - 2040
  • [9] Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
    Mahmoudi, Javad
    Sadigh-Eteghad, Saeed
    Salehi-Pourmehr, Hanieh
    Gharekhani, Afshin
    Ziaee, Mojtaba
    ADVANCED PHARMACEUTICAL BULLETIN, 2021, 11 (01) : 6 - 7
  • [10] Hydroxychloroquine in COVID-19 Patients: Pros and Cons
    Younis, Nour K.
    Zareef, Rana O.
    Al Hassan, Sally N.
    Bitar, Fadi
    Eid, Ali H.
    Arabi, Mariam
    FRONTIERS IN PHARMACOLOGY, 2020, 11
12345